Genelux Corp. (GNLX)
2.24
+0.24
(+12.00%)
USD |
NASDAQ |
Nov 18, 16:00
2.24
0.00 (0.00%)
After-Hours: 19:42
Genelux EPS Diluted (Quarterly) : -0.227 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.227 |
| June 30, 2026 | -0.2107 |
| March 31, 2026 | -0.2022 |
| December 31, 2025 | -0.2452 |
| September 30, 2025 | -0.2098 |
| June 30, 2025 | -0.1965 |
| March 31, 2025 | -0.2145 |
| December 31, 2024 | -0.2585 |
| September 30, 2024 | -0.1873 |
| June 30, 2024 | -0.2215 |
| March 31, 2024 | -0.2924 |
| December 31, 2023 | -0.2526 |
| Date | Value |
|---|---|
| September 30, 2023 | -0.2005 |
| June 30, 2023 | -0.2251 |
| March 31, 2023 | -0.4221 |
| December 31, 2022 | -0.1423 |
| September 30, 2022 | 0.2079 |
| June 30, 2022 | -0.1194 |
| March 31, 2022 | -0.161 |
| December 31, 2021 | -0.1584 |
| September 30, 2021 | -0.1247 |
| June 30, 2021 | -0.2835 |
| March 31, 2021 | -0.127 |
| March 31, 2020 | -0.1597 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.305 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
| Anika Therapeutics, Inc. | -0.0232 |
| Savara, Inc. | -0.1691 |
| Arrowhead Pharmaceuticals, Inc. | -3.029 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.28M |
| Total Expenses (Quarterly) | 10.28M |
| Enterprise Value | 82.88M |
| Earnings Yield | -39.51% |
| Normalized Earnings Yield | -39.51 |